Jensen Mark A, Li Fu-Sheng, van 't Wout Angélique B, Nickle David C, Shriner Daniel, He Hong-Xia, McLaughlin Sherry, Shankarappa Raj, Margolick Joseph B, Mullins James I
Department of Microbiology, University of Washington, Seattle, Washington 98195-8070, USA.
J Virol. 2003 Dec;77(24):13376-88. doi: 10.1128/jvi.77.24.13376-13388.2003.
Early in infection, human immunodeficiency virus type 1 (HIV-1) generally uses the CCR5 chemokine receptor (along with CD4) for cellular entry. In many HIV-1-infected individuals, viral genotypic changes arise that allow the virus to use CXCR4 (either in addition to CCR5 or alone) as an entry coreceptor. This switch has been associated with an acceleration of both CD3(+) T-cell decline and progression to AIDS. While it is well known that the V3 loop of gp120 largely determines coreceptor usage and that positively charged residues in V3 play an important role, the process of genetic change in V3 leading to altered coreceptor usage is not well understood. Further, the methods for biological phenotyping of virus for research or clinical purposes are laborious, depend on sample availability, and present biosafety concerns, so reliable methods for sequence-based "virtual phenotyping" are desirable. We introduce a simple bioinformatic method of scoring V3 amino acid sequences that reliably predicts CXCR4 usage (sensitivity, 84%; specificity, 96%). This score (as determined on the basis of position-specific scoring matrices [PSSM]) can be interpreted as revealing a propensity to use CXCR4 as follows: known R5 viruses had low scores, R5X4 viruses had intermediate scores, and X4 viruses had high scores. Application of the PSSM scoring method to reconstructed virus phylogenies of 11 longitudinally sampled individuals revealed that the development of X4 viruses was generally gradual and involved the accumulation of multiple amino acid changes in V3. We found that X4 viruses were lost in two ways: by the dying off of an established X4 lineage or by mutation back to low-scoring V3 loops.
在感染早期,1型人类免疫缺陷病毒(HIV-1)通常利用CCR5趋化因子受体(与CD4一起)进入细胞。在许多感染HIV-1的个体中,会出现病毒基因型变化,使病毒能够利用CXCR4(要么与CCR5一起,要么单独)作为进入共受体。这种转换与CD3(+) T细胞数量下降加速以及病情进展至艾滋病有关。虽然众所周知,gp120的V3环在很大程度上决定了共受体的使用情况,且V3中的带正电荷残基起着重要作用,但导致共受体使用改变的V3基因变化过程尚未得到充分理解。此外,用于病毒生物学表型分析以进行研究或临床目的的方法费力、依赖样本可用性且存在生物安全问题,因此需要可靠的基于序列的“虚拟表型分析”方法。我们引入了一种简单的生物信息学方法,对V3氨基酸序列进行评分,该方法能可靠地预测CXCR4的使用情况(敏感性为84%;特异性为96%)。这个分数(基于位置特异性评分矩阵[PSSM]确定)可以解释为揭示了使用CXCR4的倾向如下:已知的R5病毒分数低,R5X4病毒分数中等,而X4病毒分数高。将PSSM评分方法应用于11名纵向采样个体的重建病毒系统发育树,结果显示X4病毒的出现通常是渐进的,且涉及V3中多个氨基酸变化的积累。我们发现X4病毒以两种方式消失:通过已建立的X4谱系消亡,或通过突变为低评分的V3环。